6683-46-1,MFCD00052728
Catalog No.:AA00FB37

6683-46-1 | 1,2,3,4-Tetrahydro-1,1,4,4-tetramethylnaphthalene

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
96%
in stock  
$28.00   $19.00
- +
5g
96%
in stock  
$93.00   $65.00
- +
10g
98%
in stock  
$162.00   $114.00
- +
25g
98%
in stock  
$321.00   $225.00
- +
100g
98%
in stock  
$853.00 $597.00
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00FB37
Chemical Name:
1,2,3,4-Tetrahydro-1,1,4,4-tetramethylnaphthalene
CAS Number:
6683-46-1
Molecular Formula:
C14H20
Molecular Weight:
188.3086
MDL Number:
MFCD00052728
SMILES:
CC1(C)CCC(c2c1cccc2)(C)C
NSC Number:
17400
Properties
Properties
 
BP:
250.6°C at 760 mmHg  
Form:
Solid  
MP:
115-120℃  
Refractive Index:
1.5278 (589.3 nm 27℃)  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
188  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
0  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
0  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
5  

Upstream Synthesis Route

[1]Patent:US6265423,2001,B1,

[2]Patent:US5344959,1994,A,

[3]Patent:US5475022,1995,A,

[4]Patent:US5130335,1992,A,

[5]Patent:US5149705,1992,A,

[1]Patent:WO2015/188015,2015,A1,.Locationinpatent:Page/Pagecolumn31

[2]Patent:WO2018/107289,2018,A1,.Locationinpatent:Page/Pagecolumn17

[3]JournaloftheBrazilianChemicalSociety,2018,vol.29,#1,p.109-124

[4]JournalofMedicinalChemistry,1988,vol.31,#11,p.2182-2192

[5]BioorganicandMedicinalChemistry,2014,vol.22,#6,p.1948-1959

[6]Patent:WO2007/5568,2007,A1,.Locationinpatent:Page/Pagecolumn10

[7]JournaloftheAmericanChemicalSociety,1940,vol.62,p.36,43

[8]BioorganicandMedicinalChemistryLetters,2006,vol.16,#9,p.2352-2356

[9]BioorganicandMedicinalChemistry,2009,vol.17,#13,p.4740-4746

[10]EuropeanJournalofMedicinalChemistry,2012,vol.58,p.346-354

[11]LettersinDrugDesignandDiscovery,2016,vol.13,#8,p.729-733

[12]Patent:US2018/207156,2018,A1,.Locationinpatent:Paragraph0195;0196

[13]Patent:US2198374,1938,,

[1]JournalofMedicinalChemistry,1988,vol.31,#11,p.2182-2192

[2]JournaloftheAmericanChemicalSociety,1940,vol.62,p.36,43

[3]EuropeanJournalofMedicinalChemistry,2012,vol.58,p.346-354

[4]LettersinDrugDesignandDiscovery,2016,vol.13,#8,p.729-733

[5]JournaloftheBrazilianChemicalSociety,2018,vol.29,#1,p.109-124

[6]Patent:WO2018/107289,2018,A1,

[7]Patent:US2018/207156,2018,A1,

[1]JournaloftheAmericanChemicalSociety,1963,vol.85,p.173-180

[1]JournalofLabelledCompoundsandRadiopharmaceuticals,1997,vol.39,#6,p.501-507

Downstream Synthesis Route

[1]Patent:US2815382,1955,

[1]CurrentPatentAssignee:DIAXONHITGROUP-EP1541549,2005,A1Locationinpatent:Page/Pagecolumn21;40

[2]Yu,Kuo-Long;Mansuri,MuzammilM.;Starrett,JohnE.[TetrahedronLetters,1994,vol.35,#48,p.8955-8956]

[1]Patent:WO2018/107289,2018,A1.Locationinpatent:Page/Pagecolumn17

[2]JournaloftheBrazilianChemicalSociety,2018,vol.29,p.109-124

[3]OrganicandBiomolecularChemistry,2008,vol.6,p.3497-3507

[4]AngewandteChemie-InternationalEdition,2018,vol.57,p.15787-15791    Angew.Chem.,2018,vol.130,p.16013-16017,5

[5]JournalofMedicinalChemistry,1995,vol.38,p.3368-3383

[6]Patent:US8293803,2012,B2

[1]DokladyAkademiiNaukSSSR,1951,vol.80,p.369,371    Chem.Abstr.,1952,p.5022

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.2352-2356

[2]JournalofMedicinalChemistry,1988,vol.31,p.2182-2192

[3]Patent:US4703110,1987,A

[4]Heterocycles,2010,vol.81,p.2465-2470

[5]OrganicLetters,2013,vol.15,p.1378-1381

[6]Lettersindrugdesignanddiscovery,2016,vol.13,p.729-733

Literature

Title: Discovery of tetrahydrotetramethylnaphthalene analogs as adult T-cell leukemia cell-selective proliferation inhibitors in a small chemical library constructed based on multi-template hypothesis.

Journal: Bioorganic & medicinal chemistry 20090701

Title: Synthesis and antioxidant properties of novel benzimidazoles containing substituted indole or 1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene fragments.

Journal: Journal of enzyme inhibition and medicinal chemistry 20050801

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:6683-46-1 Molecular Formula|6683-46-1 MDL|6683-46-1 SMILES|6683-46-1 1,2,3,4-Tetrahydro-1,1,4,4-tetramethylnaphthalene
Catalog No.: AA00FB37
6683-46-1,MFCD00052728
6683-46-1 | 1,2,3,4-Tetrahydro-1,1,4,4-tetramethylnaphthalene
Pack Size: 1g
Purity: 96%
in stock
$28.00 $19.00
Pack Size: 5g
Purity: 96%
in stock
$93.00 $65.00
Pack Size: 10g
Purity: 98%
in stock
$162.00 $114.00
Pack Size: 25g
Purity: 98%
in stock
$321.00 $225.00
Pack Size: 100g
Purity: 98%
in stock
$853.00 $597.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00FB37
Chemical Name: 1,2,3,4-Tetrahydro-1,1,4,4-tetramethylnaphthalene
CAS Number: 6683-46-1
Molecular Formula: C14H20
Molecular Weight: 188.3086
MDL Number: MFCD00052728
SMILES: CC1(C)CCC(c2c1cccc2)(C)C
NSC Number: 17400
Properties
BP: 250.6°C at 760 mmHg  
Form: Solid  
MP: 115-120℃  
Refractive Index: 1.5278 (589.3 nm 27℃)  
Storage: Keep in dry area;2-8℃;  
Complexity: 188  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 14  
Hydrogen Bond Acceptor Count: 0  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 0  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 5  
Upstream Synthesis Route
6223-78-5    6683-46-1 

[1]Patent:US6265423,2001,B1,

[2]Patent:US5344959,1994,A,

[3]Patent:US5475022,1995,A,

[4]Patent:US5130335,1992,A,

[5]Patent:US5149705,1992,A,

6223-78-5    71-43-2    6683-46-1 

[1]Patent:WO2015/188015,2015,A1,.Locationinpatent:Page/Pagecolumn31

[2]Patent:WO2018/107289,2018,A1,.Locationinpatent:Page/Pagecolumn17

[3]JournaloftheBrazilianChemicalSociety,2018,vol.29,#1,p.109-124

[4]JournalofMedicinalChemistry,1988,vol.31,#11,p.2182-2192

[5]BioorganicandMedicinalChemistry,2014,vol.22,#6,p.1948-1959

[6]Patent:WO2007/5568,2007,A1,.Locationinpatent:Page/Pagecolumn10

[7]JournaloftheAmericanChemicalSociety,1940,vol.62,p.36,43

[8]BioorganicandMedicinalChemistryLetters,2006,vol.16,#9,p.2352-2356

[9]BioorganicandMedicinalChemistry,2009,vol.17,#13,p.4740-4746

[10]EuropeanJournalofMedicinalChemistry,2012,vol.58,p.346-354

[11]LettersinDrugDesignandDiscovery,2016,vol.13,#8,p.729-733

[12]Patent:US2018/207156,2018,A1,.Locationinpatent:Paragraph0195;0196

[13]Patent:US2198374,1938,,

110-03-2    6683-46-1 

[1]JournalofMedicinalChemistry,1988,vol.31,#11,p.2182-2192

[2]JournaloftheAmericanChemicalSociety,1940,vol.62,p.36,43

[3]EuropeanJournalofMedicinalChemistry,2012,vol.58,p.346-354

[4]LettersinDrugDesignandDiscovery,2016,vol.13,#8,p.729-733

[5]JournaloftheBrazilianChemicalSociety,2018,vol.29,#1,p.109-124

[6]Patent:WO2018/107289,2018,A1,

[7]Patent:US2018/207156,2018,A1,

97595-53-4    6683-46-1 

[1]JournaloftheAmericanChemicalSociety,1963,vol.85,p.173-180

110-03-2    71-43-2    6683-46-1 

[1]JournalofLabelledCompoundsandRadiopharmaceuticals,1997,vol.39,#6,p.501-507

Downstream Synthesis Route
6683-46-1    625-36-5    102296-82-2 

[1]Patent:US2815382,1955,

5781-53-3    6683-46-1    168301-02-8 

[1]CurrentPatentAssignee:DIAXONHITGROUP-EP1541549,2005,A1Locationinpatent:Page/Pagecolumn21;40

[2]Yu,Kuo-Long;Mansuri,MuzammilM.;Starrett,JohnE.[TetrahedronLetters,1994,vol.35,#48,p.8955-8956]

6683-46-1    27452-17-1 

[1]Patent:WO2018/107289,2018,A1.Locationinpatent:Page/Pagecolumn17

[2]JournaloftheBrazilianChemicalSociety,2018,vol.29,p.109-124

[3]OrganicandBiomolecularChemistry,2008,vol.6,p.3497-3507

[4]AngewandteChemie-InternationalEdition,2018,vol.57,p.15787-15791    Angew.Chem.,2018,vol.130,p.16013-16017,5

[5]JournalofMedicinalChemistry,1995,vol.38,p.3368-3383

[6]Patent:US8293803,2012,B2

7446-70-0    110-03-2    71-43-2    6683-46-1    22306-30-5 

[1]DokladyAkademiiNaukSSSR,1951,vol.80,p.369,371    Chem.Abstr.,1952,p.5022

6683-46-1    92050-16-3 

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.2352-2356

[2]JournalofMedicinalChemistry,1988,vol.31,p.2182-2192

[3]Patent:US4703110,1987,A

[4]Heterocycles,2010,vol.81,p.2465-2470

[5]OrganicLetters,2013,vol.15,p.1378-1381

[6]Lettersindrugdesignanddiscovery,2016,vol.13,p.729-733

Literature fold

Title: Discovery of tetrahydrotetramethylnaphthalene analogs as adult T-cell leukemia cell-selective proliferation inhibitors in a small chemical library constructed based on multi-template hypothesis.

Journal: Bioorganic & medicinal chemistry20090701

Title: Synthesis and antioxidant properties of novel benzimidazoles containing substituted indole or 1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene fragments.

Journal: Journal of enzyme inhibition and medicinal chemistry20050801

Building Blocks More >
700-00-5
700-00-5
9-Methyladenine
AA00FBCC | MFCD00047232
71989-25-8
71989-25-8
Fmoc-leu-onp
AA00FBHF | MFCD00038536
69957-80-8
69957-80-8
N-(4-chlorobenzyl)-2-propen-1-amine
AA00FBPU | MFCD07406232
65678-07-1
65678-07-1
TYRPHOSTIN AG 1024
AA00FBWG | Molecular Weight
730950-98-8
730950-98-8
3-(2,5-Dimethyl-1-propyl-1h-pyrrol-3-yl)-3-oxopropanenitrile
AA00FC0K | MFCD04621642
66183-71-9
66183-71-9
5-Ethylcarboxyl-2-pyrrolidinone
AA00FC5Y | MFCD00062673
664364-46-9
664364-46-9
2-(Pyrrolidin-3-yl)ethanol hydrochloride
AA00FCG7 | MFCD11858546
73138-88-2
73138-88-2
(PHENYLSILSESQUIOXANE)-(DIMETHYLSILOXANE) COPOLYMER
AA00FCMV
66046-42-2
66046-42-2
[3-(4-CHLOROPHENYL)-5-ISOXAZOLYL]METHANAMINE
AA00FCYW | MFCD01935956
691-57-6
691-57-6
2-Azidopropane
AA00FD31 | MFCD13248784
Submit
© 2017 AA BLOCKS, INC. All rights reserved.